The Injective protocol, a layer-1 blockchain tailored for decentralized finance, is under scrutiny as analysts assess whether its native token, INJ, can reach $50 by 2030. The protocol's unique features, such as zero gas fees and sub-second transaction finality, have positioned it as a significant player in the DeFi space. With over $45 billion in trading volume processed in 2024 and support for more than 50 decentralized applications, Injective's growth potential is notable. INJ's price history shows a peak of $52.75 in April 2024, followed by a consolidation phase. Analysts highlight strong support at $22, with current metrics indicating a circulating supply of 83.7 million INJ. Institutional partnerships and regulatory developments, such as the EU's Markets in Crypto-Assets regulation, could further influence INJ's trajectory. The protocol's deflationary tokenomics, including a burn mechanism, may also support price appreciation if demand rises. However, risks such as market volatility, regulatory changes, and competition from other layer-1 protocols could impact INJ's price. While the potential for reaching $50 exists, it hinges on successful protocol execution and favorable market conditions.